e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
China Biologic Produ
(NQ:
CBPO
)
117.98
USD
-0.28 (-0.24%)
Streaming Delayed Price
Updated: 2:51 PM EST, Jan 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about China Biologic Produ
< Previous
1
2
3
Next >
The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit
December 01, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CLLS
BEAT
GLPG
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
November 27, 2020
This morning 230 companies reached new 52-week highs. Interesting Points: The largest company by market cap to set a ...
Tags
MKSI
PGEN
ZLAB
From
Benzinga
China Biologic Products Inc (CBPO) Q3 2020 Earnings Call Transcript
November 26, 2020
CBPO earnings call for the period ending September 30, 2020.
Tags
Market News
CBPO
From
Motley Fool
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SNDX
LQDA
FATE
From
Benzinga
Earnings Scheduled For November 24, 2020
November 24, 2020
Companies Reporting Before The Bell • Analog Devices (NASDAQ:ADI) is likely to report quarterly earnings at $1.32 per ...
Tags
VNET
JWN
News
From
Benzinga
Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
November 22, 2020
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a strong note, thanks to positive vaccine data reported by Moderna...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
November 22, 2020
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a ...
Tags
LLY
LQDA
ARWR
From
Benzinga
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Small Cap
UTHR
IPOs
From
Benzinga
Stocks That Hit 52-Week Highs On Thursday
November 19, 2020
During the morning session on Thursday, 53 stocks hit new 52-week highs. Significant Points: The largest company by ...
Tags
GFL
UPWK
GLIBA
From
Benzinga
China Biologic Products Inc (CBPO) Q2 2020 Earnings Call Transcript
August 18, 2020
CBPO earnings call for the period ending June 30, 2020.
Tags
CBPO
Market News
From
Motley Fool
Earnings Scheduled For August 17, 2020
August 17, 2020
Companies Reporting Before The Bell • JD.com Inc. (NASDAQ:JD) is expected to report quarterly earnings at $0.38 per share on ...
Tags
FENG
CBPO
News
From
Benzinga
The Week Ahead In Biotech: Spotlight On Gilead, BioMarin FDA Decisions, Biotech IPOs
August 16, 2020
Biotech stocks came under pressure in the week ended Aug. 14 amid mixed earnings news flow from the sector. FDA decisions scheduled for ...
Tags
IPOs
Market News
ITOS
From
Benzinga
China Biologic Products Inc (CBPO) Q1 2020 Earnings Call Transcript
May 21, 2020
CBPO earnings call for the period ending March 31, 2020.
Tags
Market News
CBPO
From
Motley Fool
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
May 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CBPO
ADCT
BTAI
From
Benzinga
Stocks To Watch: China Biologic Products Sees RS Rating Jump To 81
May 19, 2020
China Biologic Products shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.
From
Investor's Business Daily
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
May 17, 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ...
Tags
Benzinga
RHHBY
MDT
From
Benzinga
China Biologic Products Earns Relative Strength Rating Upgrade; Hits Key Threshold
May 04, 2020
A Relative Strength Rating upgrade for China Biologic Products shows improving technical performance.
From
Investor's Business Daily
China Biologic Products Holdings Enters Oversold Territory (CBPO)
April 02, 2020
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
China Biologic Products Inc (CBPO) Q4 2019 Earnings Call Transcript
March 13, 2020
CBPO earnings call for the period ending December 31, 2019.
Tags
CBPO
Market News
From
Motley Fool
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
March 12, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CATB
TFFP
TLGT
From
Benzinga
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
March 08, 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on ...
Tags
DVAX
Previews
NSPR
From
Benzinga
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
November 15, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
News
NXTC
TNXP
From
Benzinga
China Biologic Products Inc (CBPO) Q3 2019 Earnings Call Transcript
November 14, 2019
CBPO earnings call for the period ending September 30, 2019.
Tags
Market News
CBPO
From
Motley Fool
Stocks That Hit 52-Week Highs On Thursday
November 14, 2019
During the morning session on Thursday, 84 stocks hit new 52-week highs. Areas of Interest: The largest company by market cap ...
Tags
ROAD
HUBB
AGCO
From
Benzinga
The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing
November 14, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit ...
Tags
ZSAN
BHC
FULC
From
Benzinga
Earnings Scheduled For November 13, 2019
November 13, 2019
Companies Reporting Before The Bell Meritor, Inc. (NYSE: MTOR) is projected to report quarterly earnings at $0.69 per share on ...
Tags
TSEM
News
VIPS
From
Benzinga
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
October 17, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ...
Tags
Biotech
ACHN
ALXN
From
Benzinga
APAC third quarter lending slides to two-year low
September 30, 2019
HONG KONG, Sept 30 (LPC) - Syndicated lending in Asia Pacific, excluding Japan, declined to a two-year low to US$338.76bn in the first three quarters of 2019 as the ongoing trade war between China and...
Tags
companyNews
From
Reuters: Company News
24 Stocks Moving in Tuesday's Pre-Market Session
September 24, 2019
Gainers AIM ImmunoTech Inc. (NYSE: AIM) rose 46.3% to $2.56 in pre-market trading after the company’s Ampligen received ...
Tags
QIWI
KMX
AIM
From
Benzinga
Week In Review: Investor Group Bids $4.6 Billion To Acquire China Biologic
September 21, 2019
China Biologic Products, a blood products company, received a $4.6 billion takeover offer that is similar to a proposal the company rejected one year ago.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.